Loading clinical trials...
Loading clinical trials...
A Performance Evaluation of the Nanomix eLab® C-Reactive Protein, Procalcitonin, and Lactate Assays With the Nanomix eLab System
Conditions
Interventions
Nanomix eLab® System molecular diagnostic test (non-interventional)
Locations
1
United States
UCSF- San Francisco General Hospital
San Francisco, California, United States
Start Date
December 11, 2018
Primary Completion Date
April 30, 2019
Completion Date
August 30, 2019
Last Updated
August 23, 2021
NCT06712641
NCT07533994
NCT07367113
NCT07356583
NCT06517810
NCT07172451
Lead Sponsor
Nanomix
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions